Earnings Per Share, Basic of Enlivex Therapeutics Ltd. from 31 Dec 2020 to 30 Jun 2025

Taxonomy & unit
us-gaap: USD/shares
Description
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
Summary
Enlivex Therapeutics Ltd. quarterly and annual Earnings Per Share, Basic in USD/shares history and change rate from 31 Dec 2020 to 30 Jun 2025.
  • Enlivex Therapeutics Ltd. Earnings Per Share, Basic for the quarter ending 30 Jun 2025 was -0.08, a 50% increase year-over-year.
  • Enlivex Therapeutics Ltd. annual Earnings Per Share, Basic for 2024 was -0.73, a 53% increase from 2023.
  • Enlivex Therapeutics Ltd. annual Earnings Per Share, Basic for 2023 was -1.56, a 7.7% increase from 2022.
  • Enlivex Therapeutics Ltd. annual Earnings Per Share, Basic for 2022 was -1.69, a 109% decline from 2021.
Source SEC data
View on sec.gov
Earnings Per Share, Basic, Quarterly (USD/shares)
Earnings Per Share, Basic, YoY Quarterly Change (%)
Earnings Per Share, Basic, Annual (USD/shares)
Earnings Per Share, Basic, YoY Annual Change (%)

Enlivex Therapeutics Ltd. Quarterly Earnings Per Share, Basic (USD/shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q2 2025 -0.08 +0.08 +50% 01 Apr 2025 30 Jun 2025 6-K 29 Aug 2025 2025 Q2
Q2 2024 -0.16 +0.21 +57% 01 Apr 2024 30 Jun 2024 6-K 29 Aug 2025 2025 Q2
Q2 2023 -0.37 +0.17 +31% 01 Apr 2023 30 Jun 2023 6-K 30 Aug 2024 2024 Q2
Q2 2022 -0.54 -0.37 -218% 01 Apr 2022 30 Jun 2022 6-K 01 Sep 2023 2023 Q2
Q2 2021 -0.17 01 Apr 2021 30 Jun 2021 6-K 22 Aug 2022 2022 Q2

Enlivex Therapeutics Ltd. Annual Earnings Per Share, Basic (USD/shares)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 -0.73 +0.83 +53% 01 Jan 2024 31 Dec 2024 20-F 30 Apr 2025 2024 FY
2023 -1.56 +0.13 +7.7% 01 Jan 2023 31 Dec 2023 20-F 30 Apr 2025 2024 FY
2022 -1.69 -0.88 -109% 01 Jan 2022 31 Dec 2022 20-F 30 Apr 2025 2024 FY
2021 -0.81 +0.09 +10% 01 Jan 2021 31 Dec 2021 20-F 30 Apr 2024 2023 FY
2020 -0.9 01 Jan 2020 31 Dec 2020 20-F 10 Apr 2023 2022 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.